Financial Ratios The Baldwin Insurance Group, Inc.
Stocks
BWIN
US05589G1022
Multiline Insurance & Brokers
|
Market Closed -
Other stock markets
|
Pre-market 04:33:39 pm | |||
| 26.95 USD | -1.10% |
|
27.04 | +0.33% |
| 15/07 | BofA Securities Adjusts Baldwin Insurance Group Price Target to $37 From $36 | MT |
| 23/06 | Baldwin Insurance Shares Rise After JPMorgan Upgrade | MT |
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 0.55 | 0.07 | 0.82 | 1.09 | 1.46 | ||||
Return on Total Capital | 0.73 | 0.09 | 1.14 | 1.55 | 2.02 | ||||
Return On Equity % | -5.94 | -6.59 | -15.19 | -4.05 | -5.17 | ||||
Return on Common Equity | -6.28 | -6.87 | -15.43 | -4.29 | -5.71 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 29.48 | 26.64 | 27.43 | 26.11 | 30.2 | ||||
SG&A Margin | 2.81 | 2.34 | 2.21 | 1.92 | 1.46 | ||||
EBITDA Margin % | 12.51 | 9.16 | 11.7 | 11.63 | 14.23 | ||||
EBITA Margin % | 12.02 | 8.69 | 11.23 | 11.18 | 13.8 | ||||
EBIT Margin % | 3.43 | 0.36 | 3.74 | 4.42 | 5.74 | ||||
Income From Continuing Operations Margin % | -10.25 | -7.83 | -13.46 | -2.96 | -3.6 | ||||
Net Income Margin % | -5.4 | -4.26 | -7.4 | -1.77 | -2.25 | ||||
Net Avail. For Common Margin % | -5.4 | -4.26 | -7.4 | -1.77 | -2.25 | ||||
Normalized Net Income Margin | 4.08 | -0.07 | 2.32 | -1.61 | -0.06 | ||||
Levered Free Cash Flow Margin | 10.43 | 7.55 | 22.02 | 3.73 | -1.34 | ||||
Unlevered Free Cash Flow Margin | 12.78 | 11.56 | 27.72 | 8.87 | 3.33 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.26 | 0.31 | 0.35 | 0.39 | 0.41 | ||||
Fixed Assets Turnover | 10.3 | 8.88 | 10.59 | 13.72 | 16.83 | ||||
Receivables Turnover (Average Receivables) | 2.29 | 2.25 | 2.09 | 2.07 | 4.77 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 1.07 | 1.1 | 0.9 | 0.97 | 1.16 | ||||
Quick Ratio | 0.89 | 0.93 | 0.72 | 0.8 | 0.93 | ||||
Operating Cash Flow to Current Liabilities | 0.07 | -0 | 0.04 | 0.1 | -0.03 | ||||
Days Sales Outstanding (Average Receivables) | 159.67 | 162.42 | 174.66 | 176.72 | 76.45 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 84.5 | 125.14 | 139.04 | 148.49 | 162.43 | ||||
Total Debt / Total Capital | 45.8 | 55.58 | 58.17 | 59.76 | 61.9 | ||||
LT Debt/Equity | 77.55 | 123.03 | 136.25 | 145.4 | 159.61 | ||||
Long-Term Debt / Total Capital | 42.03 | 54.64 | 57 | 58.52 | 60.82 | ||||
Total Liabilities / Total Assets | 58.71 | 67.07 | 70.91 | 71.46 | 71.92 | ||||
EBIT / Interest Expense | 0.72 | 0.05 | 0.38 | 0.5 | 0.71 | ||||
EBITDA / Interest Expense | 3.23 | 1.59 | 1.42 | 1.52 | 1.95 | ||||
(EBITDA - Capex) / Interest Expense | 2.91 | 1.23 | 1.22 | 1.19 | 1.62 | ||||
Total Debt / EBITDA | 11.55 | 12.64 | 8.36 | 7.96 | 7.46 | ||||
Net Debt / EBITDA | 9.95 | 11.59 | 7.68 | 7.17 | 6.93 | ||||
Total Debt / (EBITDA - Capex) | 12.8 | 16.3 | 9.71 | 10.2 | 8.98 | ||||
Net Debt / (EBITDA - Capex) | 11.04 | 14.95 | 8.91 | 9.19 | 8.35 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | 135.47 | 72.88 | 24.25 | 13.99 | 8.34 | ||||
Gross Profit, 1 Yr. Growth % | 150.34 | 56.23 | 27.31 | 11.37 | 25.28 | ||||
EBITDA, 1 Yr. Growth % | 278.65 | 38.09 | 60.49 | 20.46 | 25.69 | ||||
EBITA, 1 Yr. Growth % | 287.09 | 36.86 | 62.53 | 20.99 | 26.46 | ||||
EBIT, 1 Yr. Growth % | -1.47T | -74.14 | 1.75T | 65.89 | 40.46 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 94.48 | 32.05 | 113.71 | -74.95 | 31.82 | ||||
Net Income, 1 Yr. Growth % | 95.25 | 36.3 | 115.79 | -72.8 | 37.91 | ||||
Normalized Net Income, 1 Yr. Growth % | 178 | -103.74 | -456.18 | -197.05 | -95.65 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 11.03 | 14.91 | 103.92 | -74.22 | 28.81 | ||||
Accounts Receivable, 1 Yr. Growth % | 119.19 | 56.08 | 18.01 | 11.84 | 20.66 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | 799.54 | 22.95 | -11.23 | -12.8 | -10.45 | ||||
Total Assets, 1 Yr. Growth % | 88 | 20.37 | 1.15 | 0.94 | 9.26 | ||||
Tangible Book Value, 1 Yr. Growth % | 86.72 | 22.31 | -2.33 | -4.64 | 6.32 | ||||
Common Equity, 1 Yr. Growth % | 65.42 | -0.05 | -7.84 | 4.07 | 2.91 | ||||
Cash From Operations, 1 Yr. Growth % | 9 | -106.14 | -1.91T | 128.81 | -157.17 | ||||
Capital Expenditures, 1 Yr. Growth % | 16.52 | 196.91 | -7.27 | 75.86 | -3.22 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | 110.66 | 33.48 | 265.4 | -80.32 | 218.8 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 126.5 | 64.79 | 199.7 | -62.95 | -23.11 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 102.87 | 101.76 | 46.56 | 19.01 | 11.13 | ||||
Gross Profit, 2 Yr. CAGR % | 102.25 | 97.76 | 41.37 | 17.83 | 18.12 | ||||
EBITDA, 2 Yr. CAGR % | 108.61 | 118.96 | 48 | 35.8 | 25.74 | ||||
EBITA, 2 Yr. CAGR % | 107.96 | 119.98 | 48.22 | 36.82 | 26.5 | ||||
EBIT, 2 Yr. CAGR % | 83.84 | 57.09 | 83.2 | 612.96 | 52.65 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 60.89 | 60.25 | 67.99 | -26.84 | -42.54 | ||||
Net Income, 2 Yr. CAGR % | 88.23 | 63.14 | 71.5 | -23.39 | -38.75 | ||||
Normalized Net Income, 2 Yr. CAGR % | 46.73 | -70.44 | 20.74 | 70.77 | -78.91 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.49 | 13.19 | 52.57 | -27.5 | -42.38 | ||||
Accounts Receivable, 2 Yr. CAGR % | 140.77 | 84.96 | 35.72 | 14.88 | -26.18 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 446.24 | 232.57 | 4.47 | -12.02 | -11.63 | ||||
Total Assets, 2 Yr. CAGR % | 168.57 | 50.43 | 10.34 | 1.04 | 5.02 | ||||
Tangible Book Value, 2 Yr. CAGR % | 191.91 | 51.12 | 9.3 | -3.49 | 0.7 | ||||
Common Equity, 2 Yr. CAGR % | 188.12 | 28.59 | -4.02 | -2.07 | 3.49 | ||||
Cash From Operations, 2 Yr. CAGR % | 82.76 | -74.14 | 5.48 | 544.14 | 2.43T | ||||
Capital Expenditures, 2 Yr. CAGR % | 88.68 | 86 | 65.93 | 27.7 | 30.46 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 89.32 | 62.38 | 119.87 | -15.59 | -72.34 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 82.14 | 88.22 | 121.59 | 4.91 | -61.19 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 92.22 | 92.33 | 71.66 | 34.78 | 15.34 | ||||
Gross Profit, 3 Yr. CAGR % | 80.95 | 85.57 | 71.03 | 29.45 | 20.26 | ||||
EBITDA, 3 Yr. CAGR % | 72.42 | 76.62 | 96.65 | 35.38 | 34.73 | ||||
EBITA, 3 Yr. CAGR % | 72.27 | 75.51 | 98.05 | 35.59 | 35.78 | ||||
EBIT, 3 Yr. CAGR % | 21.87 | -15.23 | 217.58 | 65.45 | 314.85 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 178.56 | 50.63 | 76.39 | -10.92 | -10.97 | ||||
Net Income, 3 Yr. CAGR % | 266.21 | 69.03 | 79.08 | -7.17 | -6.8 | ||||
Normalized Net Income, 3 Yr. CAGR % | 199.17 | -59.25 | 50.32 | 4.74 | -49.68 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 69.75 | 15.3 | 37.42 | -15.66 | -12.19 | ||||
Accounts Receivable, 3 Yr. CAGR % | 126.36 | 108.38 | 59.23 | 27.24 | -13.68 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 258.68 | 232.28 | 114.13 | -1.63 | -11.5 | ||||
Total Assets, 3 Yr. CAGR % | 174 | 105.53 | 31.79 | 7.11 | 3.71 | ||||
Tangible Book Value, 3 Yr. CAGR % | 114.21 | 118.43 | 30.66 | 4.44 | -0.32 | ||||
Common Equity, 3 Yr. CAGR % | 112.17 | 102.45 | 15.07 | -1.4 | -0.43 | ||||
Cash From Operations, 3 Yr. CAGR % | 50.41 | -41.04 | 6.64 | 36.54 | 128.62 | ||||
Capital Expenditures, 3 Yr. CAGR % | 4.7 | 119.46 | 47.49 | 69.18 | 16.43 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | 141.03 | 64.93 | 112.16 | -2.3 | -34.81 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 608.25 | 73.12 | 119.36 | 21.43 | -23.52 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 82.82 | 72.46 | 58.73 | 44.25 | ||||
Gross Profit, 5 Yr. CAGR % | - | 72.29 | 63.94 | 54.74 | 46.73 | ||||
EBITDA, 5 Yr. CAGR % | - | 63.68 | 59.41 | 58.17 | 62.77 | ||||
EBITA, 5 Yr. CAGR % | - | 64.16 | 59.3 | 58 | 63.79 | ||||
EBIT, 5 Yr. CAGR % | - | -10.8 | 33.46 | 60.55 | 127.32 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 81.93 | 127.54 | 12.84 | 12.63 | ||||
Net Income, 5 Yr. CAGR % | - | 89.64 | 170.36 | 23.17 | 16.59 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 2.38 | 100.88 | 15.7 | -34.89 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | 62.66 | -4.36 | -2.93 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | 156.97 | 84.48 | 64.22 | 17.08 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 157.22 | 118.99 | 95.28 | 50.29 | ||||
Total Assets, 5 Yr. CAGR % | - | 138.38 | 90.43 | 54.71 | 20.35 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | 90.95 | 63.66 | 57.55 | 17.73 | ||||
Common Equity, 5 Yr. CAGR % | - | 71.94 | 54.48 | 51.41 | 10.29 | ||||
Cash From Operations, 5 Yr. CAGR % | - | -21.03 | 30.51 | 53.43 | -4.39 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 125.84 | 25.88 | 76.72 | 40.43 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 129.36 | 25.67 | -6.45 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 340.35 | 41.33 | 9.37 |
- Stock Market
- Stocks
- BWIN Stock
- Financials The Baldwin Insurance Group, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















